Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Prospective, Post-Market, Observational Registry Study to Observe the Performance and Safety of the Immiseal™ Dural Sealant System for Use as an Adjunct to Standard Methods of Dural Repair to Provide Watertight Closure During Neurosurgical Procedures

NCT07651826 is registered in ClinicalTrials.gov with Medprin Regenerative Medical Technologies Co., Ltd. as lead sponsor.

NCT NCT07651826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07651826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Prospective, Post-Market, Observational Registry Study to Observe the Performance and Safety of the Immiseal™ Dural Sealant System for Use as an Adjunct to Standard Methods of Dural Repair to Provide Watertight Closure During Neurosurgical Procedures
Lead sponsor
Medprin Regenerative Medical Technologies Co., Ltd.
Phase
Observational
Overall status
Recruiting
Start date
February 17, 2026
Completion date
November 23, 2026
Enrollment
85 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrospinal fluid leak, dural defect, neurosurgical procedures